European OTC Results Round-Up: Alliance Pharma, Boiron and Ipsen
Executive SummaryUK-based Alliance Pharma reported a good year for its OTC business in 2018, while French players Boiron and Ipsen endured a more difficult 12 months.
You may also be interested in...
The French health watchdog Haute Autorité de Santé's recommendation to de-reimburse homeopathic medicines ignores their health benefits and popularity among French consumers, insists Laboratoires Boiron.
J&J agrees to sell marketing rights to its OTC 1% ketoconazole dandruff treatment product to Kramer Labs in the US and Latin America, to German firm Stada in the EMEA and to UK firm Alliance Pharma for the Asia-Pacific market as it continues to spin off non-core brands and focus on its core $1bn brands.